Molecular Neurobiology
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of IJMS focuses on publishing high-quality manuscripts that report on a broad range of topics of general interest to those working in the field of molecular neurobiology. Topics include, but are not limited to, the following:
- Neurobiology
- Neurochemistry
- Neurology
- Neuropathology
- Neurophysiology
- Neuropharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Aspects of the Neurodegenerative Brain Diseases (Deadline: 10 May 2024)
- Alzheimer's Disease: From Pathogenic Mechanisms to Therapy (Deadline: 15 May 2024)
- Translational and Molecular Research of Neurological Disorders (Deadline: 15 May 2024)
- Molecular Mechanisms of Neuropsychiatric Diseases (Deadline: 20 May 2024)
- Disorders in Brain Development and Nervous System: Key Molecules and Pathology (Deadline: 20 May 2024)
- Multiplicity of Cerebrospinal Fluid Functions in Health and Disease (Deadline: 20 May 2024)
- The Multiple Mechanisms Underlying Neuropathic Pain (III) (Deadline: 20 May 2024)
- Molecular Research on Neuronal Cell Death and Neurogenesis (Deadline: 20 May 2024)
- Recent Molecular Research of Parkinson's Disease (Deadline: 25 May 2024)
- Research Advances in Neurodegeneration and Neuropathy (Deadline: 25 May 2024)
- Current Insights on Neuroprotection (Deadline: 25 May 2024)
- Molecular Mechanisms Subserving Taste and Olfaction Systems (Deadline: 30 May 2024)
- Neurometabolic Disorders in the Adults (Deadline: 30 May 2024)
- Molecular Pathology and Treatment of Neuromuscular Disease (Deadline: 30 May 2024)
- Inflammation and Neurological Diseases: Molecular Mechanisms and Therapeutic Implications (Deadline: 30 May 2024)
- Alzheimer’s Disease: From Pathogenesis to Treatment (Deadline: 30 May 2024)
- Ion Channels in the Nervous System (Deadline: 30 May 2024)
- Advances in the Research of Alzheimer’s Disease and Dietary Neuroprotective Agents (Deadline: 30 May 2024)
- Amyotrophic Lateral Sclerosis as a Systemic Disease 2.0 (Deadline: 30 May 2024)
- Plasticity of the Nervous System after Injury 2.0 (Deadline: 30 May 2024)
- Challenges and Innovation in Neurodegenerative Diseases (Deadline: 30 May 2024)
- State-of-the-Art Molecular Neurobiology in Chile 2.0 (Deadline: 30 May 2024)
- Physiology and Pathology of Neurons 2.0 (Deadline: 30 May 2024)
- Focus on Hippocampus Biology: From Neurophysiology to Dysfunctions (Deadline: 31 May 2024)
- The Pathogenesis and Pathophysiology of Epilepsy: Insights from Genetic Advances (Deadline: 31 May 2024)
- Stem Cell Therapy for Neurological Diseases (Deadline: 31 May 2024)
- Exploring Induced Pluripotent Stem Cells in Neurological Disease Modeling (Deadline: 31 May 2024)
- Investigating Molecular Footprint in Autism Spectrum Disorders: The Role of Genetics, Epigenetics and Neuroimaging in the Field (Deadline: 31 May 2024)
- Molecular Research in Psychiatric Disorders (Deadline: 31 May 2024)
- Molecular Mechanisms and Signaling Pathways in Neurodegenerative Disorders (Deadline: 31 May 2024)
- Microanatomical and Molecular Updates on Brain Aging (Deadline: 31 May 2024)
- Molecular and Cellular Mechanisms of Epilepsy 3.0 (Deadline: 31 May 2024)
- Role of Dopamine in Health and Disease: Biological Aspect 2.0 (Deadline: 31 May 2024)
- Exosomes and Extracellular Vesicles in Neuroprotection (Deadline: 31 May 2024)
- Molecular Research in Neurodevelopmental Disorders (Deadline: 31 May 2024)
- Brain Structural Plasticity: Theme and Variations (Deadline: 31 May 2024)
- Immunity in Neurodegenerative Diseases: Systemic Immune Imbalance, Neuroinflammation, and Beyond (Deadline: 31 May 2024)
- Molecular Underpinnings of Schizophrenia Spectrum Disorders (Deadline: 31 May 2024)
- New Advances in Drug-Induced Neurogenesis (Deadline: 31 May 2024)
- Molecular Research in Glioblastoma (Deadline: 31 May 2024)
- Molecular Research on the Neurodegenerative Diseases (Deadline: 31 May 2024)
- Molecular Research on Olfactory and Gustatory Receptors (Deadline: 31 May 2024)
- Neuro-Molecular Pathogenetic Mechanisms of Sudden Infant Death Syndrome (SIDS) and Other Infant Neurodevelopmental Disorders (Deadline: 31 May 2024)
- Genotoxicity in Neurodegenerative Disease and Neuropsychiatric Disorders (Deadline: 31 May 2024)
- Neural Crest Development in Health and Disease (Volume 2) (Deadline: 5 June 2024)
- State-of-the-Art Molecular Neurobiology in Poland (Deadline: 10 June 2024)
- Neurodegeneration and Countermeasures to Slow Down Its Onset (Deadline: 10 June 2024)
- Molecular Advances in Neuroradiology (Deadline: 10 June 2024)
- RNA Biomarkers in Neuropsychiatric Disorders (Deadline: 10 June 2024)
- Mitochondrial Dysfunction in Neurodegenerative Diseases (Deadline: 10 June 2024)
- Molecular and Metabolic Insights into Neuroinflammation and Neurodegeneration (Deadline: 15 June 2024)
- Molecular Mechanisms and Pathophysiology of Cerebral Gliomas: Towards Development of New Treatments (Deadline: 15 June 2024)
- Stress-Related Disorders and Depression: From Molecular Basis to Therapy (2nd Edition) (Deadline: 15 June 2024)
- Gene Transfer in Brain Disorders (Deadline: 15 June 2024)
- Molecular Researches on Ischemic Stroke 2.0 (Deadline: 20 June 2024)
- Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative Diseases 3.0 (Deadline: 20 June 2024)
- New Advances in Glioma Knowledge: From Genome to Signal Pathways Alterations (Deadline: 20 June 2024)
- Molecular Advances in Pathogenesis and Treatment of Diabetic Retinopathy (Deadline: 20 June 2024)
- Metabolic and Neurodegenerative Disorders: The Molecular and Cellular Mechanisms (Deadline: 20 June 2024)
- Biological Biomarkers of Mild Traumatic Brain Injury (Deadline: 20 June 2024)
- Genetic Heterogeneity and Molecular Mechanism of Neurodevelopmental Disorders (Deadline: 20 June 2024)
- Cognitive Dysfunction: Molecular Research and Novel Therapy (Deadline: 20 June 2024)
- Molecular Basis and Therapies in Neurological Disorders (Deadline: 25 June 2024)
- New Molecular Progression of Stem Cell Therapy for Neurological Disorders (Deadline: 25 June 2024)
- Neurospecific Substances as Biomarkers of Central Nervous System in Periphery (Deadline: 30 June 2024)
- Neurobiology of Protein Synuclein 2.0 (Deadline: 30 June 2024)
- Editorial Board Members’ Collection Series: New Insights into Neuroproteins (Deadline: 30 June 2024)
- Neuroplasticity Unveiled: Mechanisms across Neural Networks (Deadline: 30 June 2024)
- Molecular and Cellular Neurobiology of Migraine 2.0 (Deadline: 30 June 2024)
- Latest Review Papers in Molecular Neurobiology 2024 (Deadline: 30 June 2024)
- Molecular Mechanisms of Schizophrenia and Novel Treatment Targets (Deadline: 30 June 2024)
- Molecular Research of Amyotrophic Lateral Sclerosis (Deadline: 30 June 2024)
- Molecular Mechanisms and Treatments in Neurodegenerative Diseases (Deadline: 30 June 2024)
- Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders 3.0 (Deadline: 30 June 2024)
- Methodological and Theoretical Analyses of the Contribution of Immediate Early Genes to the Understanding of Brain Processing of Stressors (Deadline: 30 June 2024)
- Current Developments in Glioblastoma Research and Therapy (Deadline: 30 June 2024)
- The Role of Neurons in Human Health and Disease 2.0 (Deadline: 30 June 2024)
- Non-neuronal Cells: Novel Research Trends in Neuropathic Pain (Deadline: 30 June 2024)
- Molecular and Physiological Mechanisms of Traumatic Brain Injury (Deadline: 30 June 2024)
- Molecular Advances in Rare Inherited Neuromuscular Diseases: Therapeutic and Diagnostic (Deadline: 30 June 2024)
- Molecular and Cellular Mechanisms on Autism Spectrum Disorder (Deadline: 30 June 2024)
- Mechanisms of Antipsychotic Action: From the Researcher Bench to the Patient Bedside 2.0 (Deadline: 30 June 2024)
- Dopamine, Histamine, Serotonin—Receptors, Ligands and Their Biological Role in Central Nervous System Diseases, 2nd Edition (Deadline: 30 June 2024)
- Molecular Mechanisms and Signaling Pathways Involved in Neuropsychiatric Disorders and Neurodegenerative Diseases (Deadline: 30 June 2024)
- Mechanisms and Interventions for Neurological and Psychological Disorders 3.0 (Deadline: 30 June 2024)
- Neuroprotective Strategies 2024 (Deadline: 30 June 2024)
- Neurobiological Mechanisms of Addictive Disorders (Deadline: 30 June 2024)
- Latest Research on Brain Science: Based on Neurogenomics (Deadline: 30 June 2024)
- Molecular Research and Treatment of Neurodevelopmental Disorders (Deadline: 30 June 2024)
- Molecular Research on Depression (Deadline: 30 June 2024)
- Molecular, Cellular, and Blood Biomarkers in Acute Ischemic Stroke (Deadline: 30 June 2024)
- Emerging Neuroprotective and Regenerative Strategies for the Treatment of Demyelinating Disorders of the Central Nervous (Deadline: 30 June 2024)
- Animal Research Model for Neurological Diseases (Deadline: 30 June 2024)
- New Trends in Molecular Research of Aneurysm and Brain Injury (Deadline: 30 June 2024)
- Structural Biology of Peptides and Proteins in Alzheimer's Disease and Related Disorders (Deadline: 30 June 2024)
- Molecular Background of Posttraumatic Neurodegeneration: Previous Evidence and Future Research Directions (Deadline: 30 June 2024)
- Blood-Based Biomarkers for Alzheimer’s Disease (Deadline: 30 June 2024)
- New Insights of Biomarkers in Neurodegenerative Diseases (Deadline: 10 July 2024)
- ER Stress, Mitochondrial Dysfunction, and Neuroinflammation in Neurodegenerative Diseases (Deadline: 15 July 2024)
- Tau Pathobiology in Neurodegenerative Diseases: From Molecular Mechanisms to Therapeutic Advances (Deadline: 15 July 2024)
- Molecular Advances in Epilepsy and Seizures (Deadline: 15 July 2024)
- Abnormal Organelles and Protein Expression in Acute and Chronic Neurodegeneration (Deadline: 20 July 2024)
- Neuroinflammatory Mediator in Neurodegenerative Disease (Deadline: 20 July 2024)
- Molecular Logic of Neural Circuit Assembly in Health and Disease (Deadline: 25 July 2024)
- Neuromodulatory Effects of Serotonin (Deadline: 25 July 2024)
- Brain Plasticity in Health and Disease (Deadline: 25 July 2024)
- Molecular Mechanism behind Platinum Associated Chemotherapy-Induced Peripheral Neuropathy (CIPN) (Deadline: 30 July 2024)
- Recent Progress in Neuro-Oncology and Neuro-Inflammation: Novel Diagnostic and Therapeutic Tools (Deadline: 30 July 2024)
- Biostatistics in Brain Diseases - Future Approaches (Deadline: 30 July 2024)
- Neurodegenerative Disease: Looking for Oxidative Stress and Inflammation Mechanisms (Deadline: 30 July 2024)
- Peripheral Neuropathies: Molecular Research and Novel Therapy (Deadline: 30 July 2024)
- Mental Disorders and Translational Psychiatry: From Neurobiology to Therapeutic Perspective (Deadline: 30 July 2024)
- DNA Damage in Neurological Disorders: Etiological and Therapeutical Aspects (Deadline: 30 July 2024)
- Dementia: From Molecular Pathophysiology to Novel Therapeutic Approaches (Deadline: 30 July 2024)
- Ribbon Synapses: Molecular Mechanisms of Synaptic Signaling and Involvement in Diseases 2.0 (Deadline: 31 July 2024)
- Neurodegenerative Disease: From Molecular Basis to Therapy, 2nd Edition (Deadline: 31 July 2024)
- Molecular Mechanisms of Neurodegeneration and Neuroprotection for Retinal and Optic Nerve Diseases (Deadline: 31 July 2024)
- Role of Microglia in Several Encephalopathies (Deadline: 31 July 2024)
- Editorial Board Members’ Collection Series: “Molecular Research in Dementia” (Deadline: 31 July 2024)
- Recent Molecular Research of Neuroscience: Application of Animal Models (Deadline: 31 July 2024)
- Neurodevelopment and Novel Embryology-Based Regeneration Strategies (Deadline: 31 July 2024)
- Stem Cell Applications and Innovations in Developmental and Degenerative Disorders (Deadline: 31 July 2024)
- Mitochondrial Dysfunction and Oxidative Stress in Parkinson’s Disease (Deadline: 31 July 2024)
- Glycoscience in Neurodegenerative Disorders (Deadline: 31 July 2024)
- Interactions between the Nervous System and Gastrointestinal Motility (Deadline: 31 July 2024)
- The Role of Glia in Neuropsychiatric Disorders (Deadline: 31 July 2024)
- Inflammaging and Brain Aging (Deadline: 31 July 2024)
- Epilepsy: From Molecular Basis to Therapy (Deadline: 31 July 2024)
- Neuropathological Features of Aging and Neurodegenerative Diseases (Deadline: 31 July 2024)
- Neuroproteomics: Focus on Nervous System Function and Disease (Deadline: 31 July 2024)
- New Insights into Neurotoxicity (Deadline: 31 July 2024)
- New Mechanisms and Therapeutics in Neurological Diseases 3.0 (Deadline: 31 July 2024)
- Demyelinating Diseases: From Molecular Mechanisms to, Therapeutic Strategies 3.0 (Deadline: 31 July 2024)
- From Molecules to Medicines: Exploring Neurodegenerative Pathways for Targeted Neuropharmacology (Deadline: 31 July 2024)
- Biomarkers in Neoplastic and Degenerative CNS Diseases: Defining New Advances in Clinical Usefulness and Therapeutic Molecular Target (Deadline: 31 July 2024)
- Recent Advances in Microglia Research (Deadline: 31 July 2024)
- Role and Function of Cortex in Neurological Health and Disease (Deadline: 26 August 2024)
- Molecular Study and Treatment of Motor Neuron Diseases (Deadline: 28 August 2024)
- Molecular Pathogenesis of Ischemic and Hemorrhagic Strokes (Deadline: 30 August 2024)
- Advances in Molecular Mechanisms of Neurodegenerative Diseases (Deadline: 30 August 2024)
- Dysfunctional Neural Circuits and Impairments in Brain Function (Deadline: 30 August 2024)
- Mechanisms of Neurotoxicity (Deadline: 30 August 2024)
- Pharmacological Treatment of Neuroinflammation (Deadline: 30 August 2024)
- Advances in the Search for Protective Agents against Amyloid β-Induced Brain Degeneration (Deadline: 30 August 2024)
- Cell Pathways Underlying Neuronal Differentiation (Deadline: 30 August 2024)
- Neuropharmacology and Neurodegenerative Diseases 2.0 (Deadline: 30 August 2024)
- Neurodegenerative Diseases: Molecular Mechanisms and Therapies, 2nd Edition (Deadline: 30 August 2024)
- The Intersection of Drug Abuse, Neurotoxicity and Neurodegenerative Diseases (Deadline: 30 August 2024)
- Genetic Research in Neurological Diseases (Deadline: 31 August 2024)
- Editorial Board Members' Collection Series: “Mitochondrial Dysfunction and Neurological Disorders” (Deadline: 31 August 2024)
- New Trends in Research on Cerebral Ischemia (Deadline: 31 August 2024)
- Neuroinflammation: Advancements in Pathophysiology and Therapies (Deadline: 31 August 2024)
- Molecular Research in Epilepsy and Epileptogenesis (Deadline: 31 August 2024)
- Biological Research of Rhythms in the Nervous System (Deadline: 31 August 2024)
- Novel Concepts, New Perspectives, and Current Therapies for Parkinson’s Disease: 2nd Edition (Deadline: 31 August 2024)
- Predictive and Diagnostic Biomarkers in Inflammatory and Neurodegenerative Diseases (Deadline: 31 August 2024)
- Current Mechanisms and Pathophysiological Modifications in Brain Injury and Neurodegeneration (Deadline: 31 August 2024)
- Novel Extracellular Vesicle-Based Therapy for Central Nervous System Diseases (Deadline: 31 August 2024)
- Blast-Induced Neurotrauma: Molecular Mechanisms Supported by Comparative Experimental and Clinical Findings (Deadline: 31 August 2024)
- Brain Mechanisms behind Addictive Behaviors: New Insights and Therapeutic Approaches (Deadline: 31 August 2024)
- Molecular Research on the Effects of Mimicking Exercise on Brain Health (Deadline: 31 August 2024)
- Optimizing Mechanistic Rationale for Parkinson’s Disease Treatment (Deadline: 1 September 2024)
- Molecular Mechanisms and Novel Therapeutic Approaches for Alzheimer’s Disease (Deadline: 10 September 2024)
- From Molecular Insights to Novel Therapies: Neurological Diseases (Deadline: 20 September 2024)
- Enhancing Neurological Recovery after Stroke: Potential Therapies and Mechanisms (Deadline: 20 September 2024)
- Blood-Brain Barrier in Neuroinflammation and Neurological Diseases (Deadline: 20 September 2024)
- Depression: From Molecular Basis to Therapy (Deadline: 20 September 2024)
- Applications of Mesenchymal Stem Cells in Neuroscience 2.0 (Deadline: 20 September 2024)
- Traumatic Brain Injury/Chronic Traumatic Encephalopathy as Cause of Alzheimer’s Disease: Physics and Molecular Biology in the Genesis of Neurodegeneration? (Deadline: 20 September 2024)
- The Function of Glial Cells in the Nervous System (Deadline: 20 September 2024)
- Genomic Research in Neurobiology (Deadline: 20 September 2024)
- Novel Molecular Insights into the Most Common Muscular Dystrophy, Motor Neuron and Neuromuscular Junction Diseases
- Molecular Mechanisms of Neurological and Psychiatric Disease: A Decade of Progress (Deadline: 20 September 2024)
- Advances in Research on Neurogenesis 3.0 (Deadline: 20 September 2024)
- Mechanisms of the Endocannabinoid System and Their Role in Neurophysiology and Psychopathology (Deadline: 20 September 2024)
- Editorial Board Members’ Collection Series: “Molecular Research on Neuroprotection” (Deadline: 20 September 2024)
- Neurodegenerative Diseases: New Insights into Mechanisms, Prevention, Markers, and Therapeutic Targets (Deadline: 29 September 2024)
- Proposal of a Special Issue on: Basic, Translational and Clinical Research on Dementia—2nd Edition (Deadline: 30 September 2024)
- Circulating Biomarkers for the Diagnosis of Neurobiological Diseases—2nd Edition (Deadline: 30 September 2024)
- Molecular and Cellular Mechanisms in Mood Disorders (Deadline: 30 September 2024)
- Advances in Aging and Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics (Deadline: 30 September 2024)
- The Role of Choroid Plexus in Neurological Health (Deadline: 30 September 2024)
- Molecular Informatics and Genomics of Alzheimer’s Disease (Deadline: 30 September 2024)
- Modeling Neurological Disorders in Experimental Animals: New Insights and Emerging Roles 4.0 (Deadline: 30 September 2024)
- Molecular Advances in Alzheimer’s Disease 3.0 (Deadline: 30 September 2024)
- Advances in Neurodegenerative Diseases Research and Therapy—Third Edition (Deadline: 30 September 2024)
- New Advances of Proteins in Neuroinflammation (Deadline: 30 September 2024)
- Molecular Insights into Multiple Sclerosis (Deadline: 30 September 2024)
- Molecular Research of Alzheimer’s Disease and Nutrition Therapy (Deadline: 30 September 2024)
- Dopamine Neurons and the Genetic Pharmacology of Addiction: Unraveling Molecular Pathways (Deadline: 30 September 2024)
- Future Perspectives and Challenges in Brain Tumor (Deadline: 30 September 2024)
- Multiple Sclerosis and the Neuroinflammation (Deadline: 30 September 2024)
- Bioactive Compounds in Human Brain Structures and Diseases 2.0 (Deadline: 30 September 2024)
- Glutamatergic Signaling in the Nervous System (Deadline: 30 September 2024)
- Paradigm Shift in Central Nervous System Trauma: Molecular Targets and New Therapeutic Strategies (Deadline: 30 September 2024)
- Involvement of Neuroinflammatory Processes in Psychiatric Conditions (Deadline: 30 September 2024)
- Molecular Investigations in Neurodevelopmental Disorders (Deadline: 30 September 2024)
- Pathology and Treatment of Extracellular Vesicles in Neurodegenerative Diseases (Deadline: 30 September 2024)
- Neurodegenerative Diseases and Protein Quality Control System (Deadline: 30 September 2024)
- Molecular Mechanisms of Drug Repurposing for Neuropsychiatric Diseases (Deadline: 15 October 2024)
- Emerging Molecular Views in Neuroendocrinology (Deadline: 20 October 2024)
- The Cellular, Synaptic and Molecular Mechanisms of Action of Central Nervous System Drugs 2.0 (Deadline: 20 October 2024)
- Alzheimer’s Disease and Other Dementias—Molecular Therapeutic Approaches (Deadline: 20 October 2024)
- GABA Signaling in Health and Disease in the Nervous System, 2nd Edition (Deadline: 25 October 2024)
- Novel Insights into Microglia Heterogeneity and Neurodegeneration (Deadline: 25 October 2024)
- Molecular Mechanism in the Pathogenesis of Alzheimer’s Disease and Related Neurodegenerative Diseases (Deadline: 30 October 2024)
- Cross-Talk between Mitochondrial Dysfunction and Neuroinflammation in Central Nervous System Disorders (Deadline: 31 October 2024)
- New Trends in Neuropsychiatry Research: Behavioral and Biological Aspects (Deadline: 31 October 2024)
- Advances in Biomedical and Tissue Engineering Strategies to Cross the Blood–Brain Barrier for Next-Generation Treatments against Neurodegenerative Diseases (Deadline: 31 October 2024)
- Molecular Research on Neurotoxins (Deadline: 31 October 2024)
- Neuroimaging and Molecular Research on Depressive Disorder (Deadline: 31 October 2024)
- Spinocerebellar Ataxias: Uncovering Their Molecular Mechanisms, Biomarker Development, and Therapies (Deadline: 31 October 2024)
- Molecular Studies of Mutations Related to Neurodegenerative Diseases (Deadline: 31 October 2024)
- Advances in Synaptic Transmission and Plasticity (Deadline: 31 October 2024)
- Recent Advances in Alzheimer’s Disease—2nd Edition (Deadline: 31 October 2024)
- Advances in Research on Neurotransmitters (Deadline: 15 December 2024)
Topical Collections
Following topical collections within this section are currently open for submissions: